Liraglutide dosing schedule
Human schedule
Liraglutide is a GLP-1 analogue given as a once-daily subcutaneous injection. The figures below are a generalized reference drawn from published studies and titration protocols, not an individual prescription.
This is a concise reference to regimens described for adults; it is not an individual prescription.
| Period / condition | Dose | Escalation |
|---|---|---|
| Week 1 (start) | 0.6 mg subcutaneous, once daily | Starting dose |
| Weeks 2–4 (titration) | 1.2 → 1.8 → 2.4 mg, once daily | +0.6 mg weekly as tolerated |
| Week 5+ (maintenance) | 3.0 mg subcutaneous, once daily | Maximum in this schedule |
| Metabolic regimen (lower) | 1.8 mg subcutaneous, once daily | Alternative maximum |